Mega Lifesciences

SET:MEGA · TH4984010009

PharmaceuticalsMedium

360

Medium confidence — indicative

Value61

Profit price80

Cash yield87

Sales & asset price39

Price/Sales28

EV / Gross Profit61

Price/Book29

Quality65

Returns on capital89

Return on Capital91

Return on Equity87

Profit margins84

EBIT Margin85

Gross Profitability83

Cash truth not applicable for financial companies.

Growth60

Sales growth33

Profit growth72

Profit Growth73

Long-Term EPS Growth70

Reinvestment11

Price momentum91

Safety—

Debt load72

Debt serviceability50

Liquidity80

Sentiment43

Analyst ratings50

Expectations trend50

Opinion Changes87

Price Target Upside12

Market mood97

Value Creation13/20creating some value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Mega Lifesciences clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryThailand

IndustryPharmaceuticals

SizeMedium

TypePublic Company

ExchangeSET

Founded1982

Employees877

Websitemegawecare.com

ISINTH4984010009

Last UpdateApr 2, 2026

Indices

SET (Thailand)

Themes

DermatologyLifestyleGastroenterologyDiabetesNutraceuticalCentral Nervous SystemRespiratoryCardiovascularOncologyPharmaceuticalRetailSales

Description

Mega Lifesciences Public Company Limited operates primarily within the healthcare and pharmaceutical sector. The company focuses on manufacturing and distributing various health-related products, including but not limited to nutritional supplements,…

Analysis

Middle-of-the-road

Mega Lifesciences Public Company Limited sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is uncertain. The company scores 13/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250

2026

All-time high

Jun 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Mega Lifesciences with its peers

Penta Valent

JKT:PEVE

CountryIndonesia

IndustryHealth Care Providers & Services

SizeSmall

Full Stock Analysis →

Sarana Mitra Luas

JKT:SMIL

CountryIndonesia

IndustryTrading Companies & Distributors

SizeSmall

Full Stock Analysis →

T Man Pharmaceutical

SET:TMAN

CountryThailand

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Nakornthon Hospital

SET:NKT

CountryThailand

IndustryHealth Care Providers & Services

SizeSmall

Full Stock Analysis →

Triple Flag Precious Metals

TOR:TFPM

CountryCayman Islands

IndustryMetals & Mining

SizeMedium

Full Stock Analysis →

Helport AI

NAQ:HPAI

CountryBritish Virgin Islands

IndustrySoftware

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →